Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
RudaCure Logo
RudaCure Growth Score
62
CB Rank
104012
Heat Score
59
RudaCure is a pharmaceutical company that develops medicines for incurable diseases.
Founded
obfuscation
PrivateSeries A Incheon, Inch'on-jikhalsi, South Korea11-50 www.rudacure.com
Biotechnology
Pharmaceutical
Product Research
Overview

RudaCure
Total Funding
obfuscation
Growth Score
62
Heat Score
59

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score62
0 pts
in past quarter
Heat Score 59
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About RudaCure

CB Rank
104012
RudaCure is a pharmaceutical company that develops medicines for incurable diseases.
Founded
obfuscation
PrivateSeries A Incheon, Inch'on-jikhalsi, South Korea11-50 www.rudacure.com
Biotechnology
Pharmaceutical
Product Research

Funding Rounds

Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Ludacure Co., Ltd.
Also Known As 루다큐어
Operating Status Active
Company Type For Profit
Phone Number +82 032 724 9070
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

RCI001
A drug candidate for treating ocular surface diseases such as dry eye syndrome.
RCI002
A drug candidate targeting neuropathic pain, atopic dermatitis, and age-related macular degeneration (AMD).

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A
obfuscation
Series A - RudaCure Logo
Series A - RudaCure
3
obfuscation
— Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
CKD Venture Capital Corporation Logo
CKD Venture Capital Corporation
—
Series A - RudaCure Logo
Series A - RudaCure
—
CKD Venture Capital Corporation Logo
CKD Venture Capital Corporation
—
Series A - RudaCure Logo
Series A - RudaCure
—
CKD Venture Capital Corporation Logo
CKD Venture Capital Corporation
—
Series A - RudaCure Logo
Series A - RudaCure
—
CKD Venture Capital Corporation Logo
CKD Venture Capital Corporation
—
Series A - RudaCure Logo
Series A - RudaCure
—
CKD Venture Capital Corporation Logo
CKD Venture Capital Corporation
—
Series A - RudaCure Logo
Series A - RudaCure
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 2
News

News and Press

News•Nov 21, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 21, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

134
-95.88%
 in past month

Active Website Tech Count

19RudaCure is actively using 19 technologies for its website, according to BuiltWith. These include SPF, SSL by Default, and  Viewport Meta.

Total IP

5The intellectual property of RudaCure includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is RudaCure's headquarters? RudaCure is located in Incheon, Inch'on-jikhalsi, South Korea.Who invested in RudaCure? RudaCure has 3 investors including CKD Venture Capital Corporation and  Y&Archer.When was the last funding round for RudaCure? RudaCure closed its last funding round on
obfuscation
from a Series A round.Who are RudaCure's competitors? Alternatives and possible competitors to RudaCure may include Bausch & Lomb, Tarsus Pharmaceuticals, and  NicOx.How much funding has RudaCure raised to date? RudaCure has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|